Last week we also reported on a bi-partisan bill in the Senate that would lower the cost of insulin and cap the out-of-pocket cost to diabetes patients at $35 a month. Because it was developed by Senators Jeanne Shaheen  ...

For the past few weeks, we have been reporting that the Democratic majority in the Senate was going to try to pass a bill to lower prescription drug costs before Congress goes on its annual August recess. We said that ...

Once again, TSCL is being quoted in a number of media outlines regarding its forecast of the 2023 Social Security COLA. Among them is Yahoo Finance, which said this: “Based on new inflation data through June, the cost ...

The Federal Trade Commission (FTC) is considering the use of a rarely used anti-price discrimination law to potentially crack down on dominant companies’ unfair use of market power. The Federal Trade Commission is rampin ...

One of the goals of many members of Congress has been to lower the cost of insulin. However, the latest bill to lower prescription drug prices removes a provision to cap patients’ insulin costs at $35 per month. That ...

Extending the solvency of Social Security, along with lower prescription drug prices, has been at the top of TSCL’s agenda for several years so we are pleased the Senate is addressing those issues in this bill. The wa ...

Last week we told you that Senate Democrats have revealed they will make one last try to pass a bill to lower prescription drug costs before Congress goes on its annual August recess. That effort starts this week when bo ...

Last week a new federal rule that is supposed to give a clearer picture of what insurers and employers pay for health care went into effect. However, there are doubts about how successful it will prove to be. Patients ...